The scientific enterprise is facing significant challenges due to recent administrative policies that are severely limiting indirect grant costs, disrupting research funding, limiting communication with federal agencies, and delaying critical grant review processes. These changes are already having real and immediate impacts on labs, research institutions, and the broader biomedical innovation ecosystem.

We need your voice. AIMBE has posted a public statement on these critical issues and developed advocacy letters, below, that you can easily customize and send to your congressional representatives to urge them to protect research funding, ensure open collaboration, and support biomedical innovation.

As of July 30, 2025, AIMBE’s advocates have sent over 2,600 letters to 263 Members of Congress across 39 U.S. states on the importance of biomedical research. The collective voice of our researchers and the public elevates awareness of timely issues faced by the scientific community, informs evidence-based science policies, and ensures that healthcare innovation remains a national priority.

AIMBE Statement on the Impact of Federal Policy Changes on Biomedical Research